Literature DB >> 15300916

Combined hepatic resection with fenestration for highly symptomatic polycystic liver disease: A report on seven patients.

Guang-Shun Yang1, Qi-Gen Li, Jun-Hua Lu, Ning Yang, Hai-Bin Zhang, Xue-Ping Zhou.   

Abstract

AIM: To evaluate the immediate and long-term results in a series of patients with highly symptomatic polycystic liver disease (PLD) treated by combined hepatic resection with cystic fenestration.
METHODS: We reviewed our recent experience with a combined hepatic resection-fenestration procedure in seven highly symptomatic patients with PLD. Clinical data, liver manifestation of computed tomography (CT), and morbidity were recorded pre- and post-operation. Follow-up was made by clinical and CT examinations in all patients.
RESULTS: Symptomatic relief and reduction in abdominal girth were obtained in all patients during an average follow-up period of 20.4 mo. CT scans confirmed post-resection hypertrophy of the spared liver and lack of significant cyst progression. All patients had mild to severe ascites. Two patients were complicated with pleural effusion.
CONCLUSION: Some highly symptomatic patients with massive PLD may benefit from combined hepatic resection and fenestration at acceptable risk. To stitch the dissected hepatic ligaments could prevent the instable remnant liver from kinking and collapsing. Copyright 2004 The WJG Press ISSN

Entities:  

Mesh:

Year:  2004        PMID: 15300916      PMCID: PMC4572173          DOI: 10.3748/wjg.v10.i17.2598

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  19 in total

1.  Liver transplantation for adult polycystic liver disease.

Authors:  W K Washburn; L B Johnson; W D Lewis; R L Jenkins
Journal:  Liver Transpl Surg       Date:  1996-01

Review 2.  Adult polycystic disease of the liver.

Authors:  J N Vauthey; G J Maddern; L H Blumgart
Journal:  Br J Surg       Date:  1991-05       Impact factor: 6.939

3.  Treatment of non-parasitic cystic disease of the liver: a new approach to therapy with polycystic liver.

Authors:  T Y Lin; C C Chen; S M Wang
Journal:  Ann Surg       Date:  1968-11       Impact factor: 12.969

4.  Transverse hepatectomy for symptomatic polycystic liver disease.

Authors:  L B Johnson; P C Kuo; J S Plotkin
Journal:  Liver       Date:  1999-12

Review 5.  Surgery for adult polycystic liver disease.

Authors:  C Soravia; G Mentha; E Giostra; P Morel; A Rohner
Journal:  Surgery       Date:  1995-03       Impact factor: 3.982

6.  Bleeding oesophageal varices and hepatic dysfunction in adult polycystic kidney disease.

Authors:  P J Ratcliffe; S Reeders; J M Theaker
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-05

7.  Non-parasitic liver cysts and polycystic liver disease: results of surgical treatment.

Authors:  D Henne-Bruns; H J Klomp; B Kremer
Journal:  Hepatogastroenterology       Date:  1993-02

Review 8.  Liver transplantation for adult polycystic liver disease.

Authors:  K Swenson; P Seu; M Kinkhabwala; M Maggard; P Martin; J Goss; R Busuttil
Journal:  Hepatology       Date:  1998-08       Impact factor: 17.425

9.  Surgical management of nonparasitic cystic liver disease.

Authors:  H Sanchez; M Gagner; R L Rossi; R L Jenkins; W D Lewis; J L Munson; J W Braasch
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

10.  Functional similarities of hepatic cystic and biliary epithelium: studies of fluid constituents and in vivo secretion in response to secretin.

Authors:  G T Everson; M Emmett; W R Brown; P Redmond; D Thickman
Journal:  Hepatology       Date:  1990-04       Impact factor: 17.425

View more
  6 in total

1.  Autosomal dominant polycystic liver disease in a family without polycystic kidney disease associated with a novel missense protein kinase C substrate 80K-H mutation.

Authors:  Ramón Peces; Joost P H Drenth; Rene H M Te Morsche; Pedro González; Carlos Peces
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

Review 2.  Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Authors:  Bassam Abu-Wasel; Caolan Walsh; Valerie Keough; Michele Molinari
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 3.  Surgical management of polycystic liver disease.

Authors:  Robert T Russell; C Wright Pinson
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

4.  Treatment of polycystic liver disease with resection-fenestration and a new classification.

Authors:  Tuan-Jie Li; Hai-Bin Zhang; Jun-Hua Lu; Jun Zhao; Ning Yang; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

5.  Factors that influence outcome in non-invasive and invasive treatment in polycystic liver disease patients.

Authors:  Josue Barahona-Garrido; Jesus Camacho-Escobedo; Eduardo Cerda-Contreras; Jorge Hernandez-Calleros; Jesus K Yamamoto-Furusho; Aldo Torre; Misael Uribe
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

6.  Developments in the management of autosomal dominant polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Mir Reza Bekheirnia; Robert W Schrier
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.